Childhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Studyopen accessChildhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Study
- Other Titles
- Childhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Study
- Authors
- 이소람; 윤종혁; 임재영; 최희원; 이재민; 서진경; 김지윤; 양유진; 박경미; 임영탁; 박지경; 최은미; 심예지; 김흥식; 박상규; 공섬김; 최은진; 박은실
- Issue Date
- 2018
- Publisher
- 대한소아혈액종양학회
- Keywords
- Venous thromboembolism; Pediatric patients; Epidemiology
- Citation
- Clinical Pediatric Hematology-Oncology, v.25, no.1, pp 43 - 49
- Pages
- 7
- Indexed
- KCI
- Journal Title
- Clinical Pediatric Hematology-Oncology
- Volume
- 25
- Number
- 1
- Start Page
- 43
- End Page
- 49
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/12812
- DOI
- 10.15264/cpho.2018.25.1.43
- ISSN
- 2233-5250
2233-4580
- Abstract
- Background: Venous thromboembolism (VTE) is rare in pediatric patients compared to adults, but it’s incidence is gradually increasing. The purpose of this study was to analyze the incidence, risk factors, and prognosis of pediatric patients with VTE in Korea.
Methods: Between January 2000 and July 2017, 249,312 medical records of the patients older than 1 year who were hospitalized in the department of pediatrics of 10 university hospitals in Yeungnam region were retrospectively reviewed.
Results: The overall incidence of VTE was 4.9 per 10,000 admissions. Of the total 123 patients, 80 (65.0%) were male and the median age was 10.8 years (range, 1.0-23.5 years). Magnetic resonance imaging was performed most frequently to confirm the diagnosis of VTE (43.1%). Thrombosis occurred in the cerebral vessels (46.3%), lower extremities (23.8%), pulmonary (19.5%), abdomen (9.8%), and upper extremities (4.1%). One hundred and six patients had underlying causes such as cancer (27.6%), infection (26.8%), intravenous catheter insertion (17.9%), and surgery (14.6%). Protein C was evaluated in 39 patients (31.7%), protein S in 40 (32.5%), antithrombin (AT) III in 52 (42.3%), and homocysteine in 21 (17.1%). Among them, one patient with a family history of AT III deficiency had SERPINC gene mutation. Seventy-seven patients (62.6%) started anticoagulation treatment. Most (52.0%) were treated for more than 90 days.
Conclusion: Healthcare providers must be aware of the potential for VTE development in childhood. In the near future, a nationwide survey should be investigated to determine the incidence rate and the trends in VTE among Korean children.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.